$UiPath(PATH.US)$Hims & Hers Health(HIMS.US)$Novo Nordisk AS(NVO.US) As a UiPath long, the short interest in UiPath has now risen to control 100 million shares, which is 25% of the float. In this situation, any positive news can't push the price up.
You can refer to HIMS's short interest trend. HIMS shorts own 36% of the float, which directly caused HIMS to decline for four or five consecutive months before its settlement with NVO. Any positive news couldn't lift the price.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
